Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications 著者: Olasunkanmi O. Olaoye (10131945)

“…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”

Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications 著者: Olasunkanmi O. Olaoye (10131945)

“…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”

Research Progress on Histone Lactylation Modification in Ischemic Stroke: Mechanisms and Therapeutic Potential 著者: Wang Tingting (17406365)

主題: “…Histone lactylation modification…”

<b>Lossless Altered Histone Modification Analysis System (LAHMAS)</b>m 著者: Jamie Sperger (21646463)

“…The resultant Lossless Altered Histone Modification Analysis System (LAHMAS) employs a PDMS-silane treated glass surface immersed in silicone oil to facilitate lossless liquid handling and prevent sample evaporation. …”

Modification map illustrating the three-point force system for correcting pronation of the foot. 著者: Connor Matton (22226835)

主題:

Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in α1 Subunits. 著者: Kieran Bhave (9234643)

主題: “…substituted cysteine modification…”

Genetic modifications of Ad11 for tumor-selectivity and evaluation of tumor-selective replication. 著者: Masahisa Hemmi (21601907)

Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in β3 Subunits. 著者: Kieran Bhave (9234643)

主題: “…substituted cysteine modification…”

Killing horizons naturally define asymptotic symmetries and this could hint at modifications of gravity 著者: Níckolas de Aguiar Alves (19534192)

Characteristics of the interventions: tailoring, modification, how well (planned) and how well (actual). 著者: Olivia Hawksworth (19109815)

“…<p>Characteristics of the interventions: tailoring, modification, how well (planned) and how well (actual).…”

Table 2_Immune and inflammatory mechanisms in asthma: insights into epigenetic modifications.docx 著者: Haixia Fan (394144)

Table 1_Immune and inflammatory mechanisms in asthma: insights into epigenetic modifications.docx 著者: Haixia Fan (394144)

Lifestyle modification, association (X2) academic program, sex (n = 1735). 著者: Yolanda E. Salazar-Granizo (19367107)

主題:

Impact of RNA modification gene deletions on fitness during growth in sub-MIC tobramycin. 著者: Léo Hardy (22538036)

主題:

Table 2_Survival strategies of mycoplasmas: the critical role of post-translational modifications.docx 著者: Tingting Li (10553)

主題: “…post-translational modifications…”

Model-inferred target product parameter values for population modification gene drive systems. 著者: Agastya Mondal (18626010)

“…<p>Model-inferred target product parameter values for population modification gene drive systems.</p>…”

Fluorinated Modification as a Simple Strategy That Effectively Enhances the Stability and Activity of Antimicrobial Peptides 著者: Xu Ouyang (9326058)

主題:

Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in γ2L Subunits. 著者: Kieran Bhave (9234643)

主題: “…substituted cysteine modification…”

Additional file 3 of Exploring modifications to rapid response systems in Norwegian hospital units 著者: Jonas Torp Ohlsen (22678477)

主題:

Pharmacologic modification of the tumor microenvironment reduces astrogliosis and harmonizes astrocytic GLT1 expression. 著者: Mitrajit Ghosh (462069)

主題: “…pharmacologically induced modification…”